Literature DB >> 23340180

MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma.

Lu Zhang1, Zhi-Jun Sun, Yansong Bian, Ashok B Kulkarni.   

Abstract

Here in, we investigated the mechanism underlying overexpression of miR-135b in the human head and neck squamous cell carcinoma (HNSCC) cell lines and in the HNSCC mouse model. Exogenous expression of miR-135b in these cell lines increased cell proliferation, migration, and colony formation. Gene silencing analysis revealed that miR-135b affects a regulator that inhibits hypoxia-inducible factor (HIF). Increased miR-135b expression was positively correlated with HIF-1α expression and microvessel density in the HNSCC model. Thus, our data demonstrate that miR-135b acts as a tumor promoter by promoting cancer cell proliferation, colony formation, survival, and angiogenesis through activation of HIF-1α in HNSCC. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340180      PMCID: PMC3660136          DOI: 10.1016/j.canlet.2013.01.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  52 in total

1.  Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer.

Authors:  Remco Nagel; Carlos le Sage; Begoña Diosdado; Maike van der Waal; Joachim A F Oude Vrielink; Anne Bolijn; Gerrit A Meijer; Reuven Agami
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

2.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma.

Authors:  Chung-Ji Liu; Meng-Miao Tsai; Pei-Shih Hung; Shou-Yen Kao; Tsung-Yun Liu; Kou-Juey Wu; Shih-Hwa Chiou; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

3.  MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy.

Authors:  Michael Augustine Ko; Guan Zehong; Carl Virtanen; Maha Guindi; Thomas K Waddell; Shaf Keshavjee; Gail E Darling
Journal:  Ann Thorac Surg       Date:  2012-08-29       Impact factor: 4.330

4.  MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

Authors:  L Scapoli; A Palmieri; L Lo Muzio; F Pezzetti; C Rubini; A Girardi; F Farinella; M Mazzotta; F Carinci
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

5.  Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.

Authors:  Zhi-Jun Sun; Gang Chen; Wei Zhang; Xiang Hu; Yang Liu; Qian Zhou; Ling-Xing Zhu; Yi-Fang Zhao
Journal:  Mol Pharmacol       Date:  2010-10-19       Impact factor: 4.436

Review 6.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

Review 7.  Maximizing mouse cancer models.

Authors:  Kristopher K Frese; David A Tuveson
Journal:  Nat Rev Cancer       Date:  2007-09       Impact factor: 60.716

8.  Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.

Authors:  Yansong Bian; Anita Terse; Juan Du; Bradford Hall; Alfredo Molinolo; Pin Zhang; Wanjun Chen; Kathleen C Flanders; J Silvio Gutkind; Lalage M Wakefield; Ashok B Kulkarni
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

Review 9.  MicroRNAs: novel regulators in the hallmarks of human cancer.

Authors:  Kai Ruan; Xiaoguang Fang; Gaoliang Ouyang
Journal:  Cancer Lett       Date:  2009-05-22       Impact factor: 8.679

10.  MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.

Authors:  Aoife J Lowery; Nicola Miller; Amanda Devaney; Roisin E McNeill; Pamela A Davoren; Christophe Lemetre; Vladimir Benes; Sabine Schmidt; Jonathon Blake; Graham Ball; Michael J Kerin
Journal:  Breast Cancer Res       Date:  2009-05-11       Impact factor: 6.466

View more
  42 in total

1.  MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.

Authors:  Anna Aakula; Suvi-Katri Leivonen; Petteri Hintsanen; Tero Aittokallio; Yvonne Ceder; Anne-Lise Børresen-Dale; Merja Perälä; Päivi Östling; Olli Kallioniemi
Journal:  Mol Oncol       Date:  2015-03-21       Impact factor: 6.603

2.  Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma.

Authors:  Lin-Lin Bu; Wei-Wei Deng; Cong-Fa Huang; Bing Liu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.

Authors:  Cong-Cong Wu; Hao Li; Yao Xiao; Lei-Lei Yang; Lei Chen; Wei-Wei Deng; Lei Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  J Mol Histol       Date:  2018-05-30       Impact factor: 2.611

4.  Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma.

Authors:  Lin-Lin Bu; Guang-Tao Yu; Wei-Wei Deng; Liang Mao; Jian-Feng Liu; Si-Rui Ma; Teng-Fei Fan; Bradford Hall; Ashok B Kulkarni; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2016-01-19       Impact factor: 8.110

5.  Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma.

Authors:  Zhi-Li Zhao; Si-Rui Ma; Wei-Ming Wang; Cong-Fa Huang; Guang-Tao Yu; Tian-Fu Wu; Lin-Lin Bu; Yu-Fan Wang; Yi-Fang Zhao; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

6.  Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma.

Authors:  Lei Wu; Guang-Tao Yu; Wei-Wei Deng; Liang Mao; Lei-Lei Yang; Si-Rui Ma; Lin-Lin Bu; Ashok B Kulkarni; Wen-Feng Zhang; Lu Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

Review 7.  Reciprocal regulations between miRNAs and HIF-1α in human cancers.

Authors:  Wanli Yang; Jiaojiao Ma; Wei Zhou; Bo Cao; Xin Zhou; Hongwei Zhang; Qingchuan Zhao; Liu Hong; Daiming Fan
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

8.  MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2.

Authors:  Yuqi He; Jianxun Wang; Jiheng Wang; Victoria Yee-Wa Yung; Emily Hsu; Aiqin Li; Qian Kang; Junbiao Ma; Qingfeng Han; Peng Jin; Rui Xing; Youyong Lu; Jianqiu Sheng
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

9.  Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.

Authors:  Yue Xu; Shuhua Zhao; Manhua Cui; Qiang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 10.  Smoking and microRNA dysregulation: a cancerous combination.

Authors:  Navneet Momi; Sukhwinder Kaur; Satyanarayana Rachagani; Apar K Ganti; Surinder K Batra
Journal:  Trends Mol Med       Date:  2013-11-13       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.